Friday, July 10, 2026

pharma · COVID-19

Labiana Health

Hipra Human Health is a pharma organization headquartered in EU. Primary therapeutic focus areas include COVID-19. NovaPharmaNews links 2 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from

ES HQ
1958 Founded
318 Employees
EMA registrant Type
Company details
Status
Public
HQ
ES
Founded
1958
Employees
318
Programs
2
Drugs
6
Patents
0
Clinical program

COVID-19 Vaccine HIPRA

Phase 2 · mab · COVID-19

COVID-19 Vaccine HIPRA for COVID-19 is a Phase 2 program (mab) at Hipra Human Health S.L. with 1 ClinicalTrials.gov record(s).

Internal code HAN-01

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Hipra Human Health S.L.
Phase
Phase 2
Modality
mab
Indication
COVID-19
Status
completed
Trials
1